Publications by authors named "Michael A Golafshar"

Claim this Profile
E
Exome Sequencing Enhances Screening for Familial Hypercholesterolemia Within a Multi-Site Healthcare System.
N Jewel Samadder, Mariah Schroeder, Molly M Voss, Fadi Shamoun, Iftikhar Kullo, Michael A Golafshar

Circ Genom Precis Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Cancer Susceptibility Gene Testing in Unselected Patients with Malignant Melanoma: A Multicenter Prospective Study.
Collin M Costello, Andy Ho, Jacob Kechter, Robert L Nussbaum, Edward D Esplin, Michael A Golafshar

J Am Acad Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Genetic Testing in Patients with Bone and Soft Tissue Sarcoma: A Prospective Multicenter Study to Evaluate Cancer Susceptibility.
Isaak Ailts, Michael A Golafshar, Katie L Kunze, Margaret Klint, Kathleen Barrus

Int J Mol Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial.
Robert W Mutter, Michael A Golafshar, Matthew R Buras, Bryce P Comstock, Maddi Jacobson

Int J Radiat Oncol Biol Phys· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenic germ line variants in a prospective multicenter cohort of patients with multiple myeloma.
Julia Erin Wiedmeier-Nutor, Michael A Golafshar, Katie L Kunze, Edward D Esplin, Robert L Nussbaum

Blood Neoplasia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Pathogenic Variants Identified in Patients With Genitourinary Malignancies Undergoing Universal Testing: A Multisite Single-Institution Prospective Study.
Mouneeb M Choudry, Adri M Durant, Victoria S Edmonds, Christopher J Warren, Katie L Kunze, Michael A Golafshar

J Urol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exome Sequencing Identifies Carriers of the Autosomal Dominant Cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations.
N Jewel Samadder, Emily Gay, Vanda Lindpere, Michelle L Bublitz, Lorelei A Bandel, Michael A Golafshar

JCO Precis Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery.
Brady S Laughlin, Kimberly S Corbin, Diego Augusto Santos Toesca, Cameron S Thorpe, Michael A Golafshar

Int J Radiat Oncol Biol Phys· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Genetic Testing in Unselected Squamous and Non-Squamous Head and Neck Cancers.
Daniela A Brake, Beau M Idler, Katie L Kunze, Michael A Golafshar, Brandie Heald

Laryngoscope· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology Program.
Jeremy C Jones, Michael A Golafshar, Tucker W Coston, Rohit Rao, Ewa Wysokinska

Cureus· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term experience with intraoperative electron radiation therapy boost in extremity sarcoma.
Brady S Laughlin, Michael A Golafshar, Keldon Lin, Krista Goulding, Kimberly Roesler

J Surg Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy.
Brady S Laughlin, Molly M Voss, Diego A S Toesca, Thomas Daniels, Michael A Golafshar

Adv Radiat Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Versus Caregiver: Correlation and Differences in Pediatric Quality of Life Using a Prospective Registry in a Large-Volume, Multisite Practice.
Matthew R Buras, William G Breen, Nadia N Laack, Tamara Vern- Gross, Isabella Zaniletti, Michael A Golafshar

Int J Radiat Oncol Biol Phys· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery.
Cameron S Thorpe, Todd A DeWees, Brady S Laughlin, Laura A Vallow, Dee Seneviratne, Michael A Golafshar

Adv Radiat Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes for patients with breast cancer undergoing radiotherapy: A single-center registry experience.
Brady S Laughlin, Ronik S Bhangoo, Cameron S Thorpe, Michael A Golafshar, Todd A DeWees

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Experience Using Proton Beam Therapy for Extremity Soft Tissue Sarcoma: A Multicenter Study.
Brady S Laughlin, Michael A Golafshar, Safia Ahmed, Matthew Prince, Justin D Anderson

Int J Part Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study.
Pedro L S Uson, Douglas Riegert-Johnson, Lisa Boardman, John Kisiel, Luke Mountjoy, Michael A Golafshar

Clin Gastroenterol Hepatol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of Perceived Lifetime Breast Cancer Risk to Calculated Lifetime Risk Using the Gail Risk Assessment Tool.
Jaya Mehta, Kathy L MacLaughlin, Denise M Millstine, Stephanie S Faubion, Mark R Wallace, Michael A Golafshar

J Womens Health (Larchmt)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective Study.
Pedro Ls Uson Junior, Katie L Kunze, Michael A Golafshar, Douglas Riegert-Johnson, Lisa Boardman

Cancer Prev Res (Phila)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.
Jonathon W Senefeld, Patrick W Johnson, Katie L Kunze, Evan M Bloch, Noud van Helmond, Michael A Golafshar

PLoS Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors.
Katie L Kunze, Patrick W Johnson, Noud van Helmond, Jonathon W Senefeld, Molly M Petersen, Michael A Golafshar

Nat Commun· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Experience with Proton Beam Therapy for Differentiated Thyroid Cancer.
Nathan Y Yu, Aditya Khurana, Daniel J Ma, Michelle A Neben-Wittich, Michael A Golafshar

Int J Part Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma.
Jonathon W Senefeld, Patrick W Johnson, Katie L Kunze, Noud van Helmond, Stephen A Klassen, Michael A Golafshar

medRxiv· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of Potential Inequities in Breast Cancer Incidence in New Mexico Through Bayesian Disease Mapping.
David Zahrieh, Michael A Golafshar, Samir H Patel, Todd A DeWees

Prev Chronic Dis· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience.
Ronik S Bhangoo, Trey C Mullikin, Jonathan B Ashman, Tiffany W Cheng, Michael A Golafshar

Adv Radiat Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis